tiprankstipranks
Know Labs (KNW)
NYSE MKT:KNW
US Market
Holding KNW?
Track your performance easily

Know Labs (KNW) Earnings Date & Reports

66 Followers

Earnings Data

Report Date
Feb 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-$0.05
Last Year’s EPS
-$0.04
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 15, 2024
|
% Change Since: -35.00%
|
Next Earnings Date:Feb 12, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of promising technological advancements and clinical results, coupled with financial challenges and a need for further capital. The company is making significant strides in product development and intellectual property, but faces issues with cash reserves and shareholder equity.
Company Guidance
During the Know Labs Q2 2024 earnings call, the company provided several updates and guidance on its progress across key work streams. The company highlighted the development of its Generation 1 and Generation 2 (KnowU) noninvasive continuous glucose monitoring devices, with the latter being smaller, lighter, and equipped with built-in machine learning capabilities. Clinical trials have been promising, with a mean absolute relative difference (MARD) of 11.1% achieved, and plans to improve this to 10% or less. Financially, Know Labs reported an operating loss of $4.73 million, a slight improvement from the previous year, and maintained a cash balance of $4.71 million as of March 31, 2024. The company has secured up to $12 million in funding to support its core work streams and plans to raise additional funds through equity offerings to address its negative shareholder equity of $1.75 million. Know Labs is also actively expanding its intellectual property portfolio, with over 300 patents issued or pending globally. The company is positioning itself to achieve FDA clearance and commercialize its innovative glucose monitoring technology while exploring international opportunities.
Gen 2 Device Development - KnowU
The KnowU, a wearable noninvasive continuous glucose monitoring device, was announced on February 27. It is significantly smaller, lighter, includes onboard computing power, and built-in machine learning capabilities.
Positive Clinical Trial Results
An internal trial with more than 30 participants showed a mean absolute relative difference (MARD) of 11.1%, indicating promising accuracy of the glucose monitoring technology.
Significant Intellectual Property Growth
Over 300 patents issued, pending, and in process, reflecting innovation in radio frequency spectroscopy technology.
Funding Agreement Secured
Entered into a funding agreement for an investment of up to $12 million with Lind Global Fund II LP to accelerate development.
Engagement with Diabetes Community
Participated in significant conferences like ATTD, where the KnowU was displayed, and received an emerging technology grant as an outstanding startup.
Reduction in Operating Loss
Operating loss decreased by 1.7% from $4.81 million in Q2 fiscal 2023 to $4.73 million in Q2 fiscal 2024.
---

Know Labs (KNW) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

KNW Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 12, 20252025 (Q1)
-0.05 / -
-0.04
Nov 15, 20242024 (Q4)
-0.05 / -0.08
-0.05-60.00% (-0.03)
Aug 14, 20242024 (Q3)
-0.06 / -0.05
-0.1872.22% (+0.13)
May 15, 20242024 (Q2)
-0.05 / -0.07
-0.130.00% (+0.03)
Feb 14, 20242024 (Q1)
- / -0.04
-0.0850.00% (+0.04)
Dec 19, 20232023 (Q4)
0.02 / -0.05
0.04-225.00% (-0.09)
Aug 14, 20232023 (Q3)
-0.02 / -0.18
-0.02-800.00% (-0.16)
May 15, 20232023 (Q2)
- / -0.10
-0.03-233.33% (-0.07)
Feb 14, 20232023 (Q1)
- / -0.08
-0.02-300.00% (-0.06)
Dec 20, 20222022 (Q4)
- / -
-0.221
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

KNW Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 15, 2024$0.22$0.21-4.55%
Aug 14, 2024$0.33$0.31-6.06%
May 15, 2024$0.70$0.700.00%
Feb 14, 2024$0.55$0.48-12.73%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Know Labs (KNW) report earnings?
Know Labs (KNW) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
    What is Know Labs (KNW) earnings time?
    Know Labs (KNW) earnings time is at Feb 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is KNW EPS forecast?
          KNW EPS forecast for the fiscal quarter 2025 (Q1) is -$0.05.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis